Adial Pharmaceuticals, Inc.

NASDAQ (USD): Adial Pharmaceuticals, Inc. (ADIL)

Last Price

0.978

Today's Change

-0.002 (0.20%)

Day's Change

0.96 - 1.01

Trading Volume

116,267

Overview

Market Cap

6 Million

Shares Outstanding

6 Million

Avg Volume

162,625

Avg Price (50 Days)

1.05

Avg Price (200 Days)

1.18

PE Ratio

-0.33

EPS

-2.94

Earnings Announcement

31-Mar-2025

Previous Close

0.98

Open

1.00

Day's Range

0.96 - 1.0099

Year Range

0.77 - 4.17

Trading Volume

116,267

Price Change Highlight

1 Day Change

-0.19%

5 Day Change

-4.11%

1 Month Change

-6.85%

3 Month Change

-11.08%

6 Month Change

-16.40%

Ytd Change

-7.73%

1 Year Change

-21.12%

3 Year Change

-98.29%

5 Year Change

-98.05%

10 Year Change

-99.03%

Max Change

-99.03%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment